STOCK TITAN

Ra Medical Systems to Participate in the Piper Sandler Virtual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ra Medical Systems, Inc. (NYSE: RMED) has announced its participation in the Piper Sandler 32nd Annual Health Care Conference, taking place virtually from December 1-3, 2020. The company specializes in excimer laser systems for treating vascular and dermatological diseases. Investors are invited to arrange 1x1 meetings with management through their Piper Sandler representatives. Ra Medical’s DABRA and Pharos excimer laser systems have received FDA clearance for treating chronic total occlusions and various skin conditions, respectively.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif.--()--Ra Medical Systems, Inc. (NYSE: RMED) , a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will participate in the Piper Sandler 32nd Annual Health Care Conference being held virtually on December 1-3, 2020.

Investors interested in a 1x1 meeting with Ra Medical management during the conference should contact their Piper Sandler representative.

About Ra Medical Systems

Ra Medical Systems commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017 the DABRA excimer laser system received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions, or CTOs, in patients with symptomatic infrainguinal lower extremity vascular disease with an intended use for ablating a channel in occlusive peripheral vascular disease. The Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are both based on Ra Medical’s core excimer laser technology platform and deploy similar mechanisms of action. Ra Medical manufactures DABRA and Pharos excimer lasers and catheters in a 32,000-square-foot facility located in Carlsbad, Calif. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in controlled environments.

Contacts

At the Company:
Andrew Jackson
Chief Financial Officer, Ra Medical Systems
760-496-9540
ajackson@ramed.com

Investors:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

FAQ

What is the date of Ra Medical Systems' participation in the Piper Sandler 32nd Annual Health Care Conference?

Ra Medical Systems will participate in the Piper Sandler 32nd Annual Health Care Conference virtually from December 1-3, 2020.

How can investors meet with Ra Medical management during the conference?

Investors interested in a 1x1 meeting with Ra Medical management during the conference should contact their Piper Sandler representative.

What types of diseases do Ra Medical's excimer laser systems treat?

Ra Medical's excimer laser systems treat vascular diseases, including chronic total occlusions, and dermatological diseases such as psoriasis and vitiligo.

What FDA clearances do Ra Medical's laser systems have?

The DABRA excimer laser system received FDA 510(k) clearance for crossing chronic total occlusions, while the Pharos excimer laser system is FDA-cleared for treating various skin conditions.

Where does Ra Medical manufacture its excimer laser systems?

Ra Medical manufactures its excimer laser systems in a 32,000-square-foot facility located in Carlsbad, California.

Ra Medical Systems, Inc.

NYSE:RMED

RMED Rankings

RMED Latest News

RMED Stock Data

3.84M
4.60M
36.85%
11%
1.26%
Medical Devices
Healthcare
Link
United States
Fort Mill